• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
  • Donate
Home / Ask the Expert / Enbrel in a 78 year old woman/ Is it worth risk?

Enbrel in a 78 year old woman/ Is it worth risk?

April 9, 2007 By Arthritis Center

Question

I am a pediatrician who is not very familiar with Enbrel. My mother is 78 years old and has been taking NSAIDS for RA which she has had for over 30 years. Her wrist, elbows, and hands are severely deformed, but she has previously refused to try other forms of treatment, except prednisone which made her sick. Her doctor has suggested Enbrel. Considering her age and the probable condition of her joints due to longstanding RA, is it worth the risk?

Answer

As you know, it is impossible to make clinical assessements without seeing her, but let me make some general comments. In terms of benefits, I have been amazed that many patients with “endstage” or “burnt out” RA often will get a marked symtomatic improvement with the TNF agents such as Enbrel. Certainly patients with continuing inflammation, morning stiffness, joint swelling, elevated ESR will respond. There is also some evidence that the late stage RA will respond as well as early RA in terms of preventing x-ray damage. In terms of risk, all 78 year olds are not alike. If your mother has poor overall health status with multiple other problems, then she might be at increased risk for side effects. I know of no study that shows that age itself is a risk factor for problems. Ultimately its your mother’s quality of life that needs to be carefully looked at.

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Primary Sidebar

Ask The Expert Topics

  • Alternative Therapies
  • Ankylosing Spondylitis
  • Associated With Other Illnesses
  • Bursitis and Tendinitis
  • Corticosteroids
  • Diet and Exercise
  • Disease Modifying Antirheumatic Drugs (DMARDs)
  • Enteropathic Arthritis
  • Fibromyalgia
  • General Arthritis
  • Gout, Pseudogout, Other
  • Infectious Arthritis
  • Myositis
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Osteoarthritis
  • Osteonecrosis
  • Osteoporosis
  • Polymyalgia Rheumatica
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Regional Pain: Back and Neck
  • Rehabilitation
  • Rheumatoid Arthritis
  • Surgical Therapy
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis
  • Vasculitis
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2023 Johns Hopkins Arthritis Center
Patient Privacy